Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference

Rhea-AI Summary

Biofrontera Inc. (Nasdaq: BFRI) has announced that CEO Erica Monaco will present at the Roth Inaugural Healthcare Opportunities Conference on October 6, 2022, at 8:30 a.m. Eastern Time in New York City. The company invites investors attending the conference to schedule one-on-one meetings with management.

Biofrontera specializes in dermatological products, focusing on treatments like photodynamic therapy and topical antibiotics for conditions such as actinic keratoses and impetigo.

WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will also be participating in one-on-one investor meetings at the conference.

Event:	Roth Inaugural Healthcare Opportunities Conference
Date:	Thursday, October 6, 2022
Time:	8:30 a.m. Eastern Time

Investors registered for the conference are encouraged to contact their Roth representative to schedule a one-on-one meeting with management during the conference.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

# # #

FAQ

What event will Biofrontera attend on October 6, 2022?

Biofrontera will present at the Roth Inaugural Healthcare Opportunities Conference.

Who is presenting at the Roth Conference for Biofrontera?

CEO Erica Monaco will represent Biofrontera at the event.

When is the Roth Inaugural Healthcare Opportunities Conference?

The conference is scheduled for October 6, 2022.

What time will the Biofrontera presentation occur?

The presentation will take place at 8:30 a.m. Eastern Time.

How can investors schedule meetings with Biofrontera management?

Investors at the conference can contact their Roth representative to set up one-on-one meetings.

What treatments does Biofrontera specialize in?

Biofrontera specializes in dermatological products, focusing on photodynamic therapy and topical antibiotics.